Literature DB >> 9728057

Interleukin-6 production in hemorrhagic shock is accompanied by neutrophil recruitment and lung injury.

C Hierholzer1, J C Kalff, L Omert, K Tsukada, J E Loeffert, S C Watkins, T R Billiar, D J Tweardy.   

Abstract

Hemorrhagic shock (HS) initiates an inflammatory cascade that includes the production of cytokines and recruitment of neutrophils (PMN) and may progress to organ failure, inducing acute respiratory distress syndrome (ARDS). To examine the hypothesis that interleukin-6 (IL-6) contributes to PMN infiltration and lung damage in HS, we examined the lungs of rats subjected to unresuscitated and resuscitated HS for the production of IL-6 and activation of Stat3. Using semiquantitative RT-PCR, we found a striking increase in IL-6 mRNA levels only in resuscitated HS, with peak levels observed 1 h after initiation of resuscitation. Increased IL-6 protein expression was localized to bronchial and alveolar cells. Electrophoretic mobility shift assay of protein extracts from shock lungs exhibited an increase in Stat3 activation with kinetics similar to IL-6 mRNA. In situ DNA binding assay determined Stat3 activation predominantly within alveoli. Intratracheal instillation of IL-6 alone into normal rats resulted in PMN infiltration into lung interstitium and alveoli, marked elevation of bronchoalveolar lavage cellularity, and increased wet-to-dry ratio. These findings indicate that IL-6 production and Stat3 activation occur early in HS and may contribute to PMN-mediated lung injury, including ARDS after HS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9728057     DOI: 10.1152/ajplung.1998.275.3.L611

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  28 in total

1.  Induction of a rat enteric defensin gene by hemorrhagic shock.

Authors:  M R Condon; A Viera; M D'Alessio; G Diamond
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Resveratrol Improves Survival and Prolongs Life Following Hemorrhagic Shock.

Authors:  Ahmar Ayub; Ninu Poulose; Raghavan Raju
Journal:  Mol Med       Date:  2015-04-13       Impact factor: 6.354

3.  Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase.

Authors:  L Liaudet; F G Soriano; E Szabó; L Virág; J G Mabley; A L Salzman; C Szabo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

4.  Macrophage-derived chemokine (CCL22) is a novel mediator of lung inflammation following hemorrhage and resuscitation.

Authors:  Jillian R Richter; Jeffrey M Sutton; Ritha M Belizaire; Lou Ann Friend; Rebecca M Schuster; Taylor A Johannigman; Steven G Miller; Alex B Lentsch; Timothy A Pritts
Journal:  Shock       Date:  2014-12       Impact factor: 3.454

5.  Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice.

Authors:  G Sass; K Koerber; R Bang; H Guehring; G Tiegs
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

6.  Restoration of lung surfactant protein D by IL-6 protects against secondary pneumonia following hemorrhagic shock.

Authors:  Stephen Thacker; Ana Moran; Mihalis Lionakis; Mary-Ann A Mastrangelo; Tripti Halder; Maria del Pilar Huby; Yong Wu; David J Tweardy
Journal:  J Infect       Date:  2013-11-27       Impact factor: 6.072

Review 7.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

Review 8.  Markers of early disease and prognosis in COPD.

Authors:  Morten Dahl; Børge G Nordestgaard
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15

9.  Interleukin-6 as an early marker for fat embolism.

Authors:  R Yoga; Jc Theis; M Walton; W Sutherland
Journal:  J Orthop Surg Res       Date:  2009-06-13       Impact factor: 2.359

Review 10.  Hypothermia in bleeding trauma: a friend or a foe?

Authors:  Tareq Kheirbek; Ashley R Kochanek; Hasan B Alam
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-12-23       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.